AI Article Synopsis
- TEVAR (thoracic endovascular aortic repair) is becoming more popular because it has lower risks compared to traditional open surgery, prompting a study to assess its effectiveness.
- A total of 16 patients aged 20 to 78 underwent the procedure for various reasons, including large aortic diameters and traumatic ruptures, with a mean follow-up period of 18 months.
- Results showed high technical success, as most patients had their aneurysms effectively excluded, and while some experienced complications like strokes, there were no deaths related to the surgery, indicating promising intermediate outcomes and potential for broader use of TEVAR.
Article Abstract
Background: The number of cases employing thoracic endovascular aortic repair (TEVAR) has been increasing due to lower morbidity and mortality compared to open repair technique. The aim of this study is to evaluate the outcome of TEVAR for thoracic aortic diseases.
Materials And Methods: Sixteen patients underwent TEVAR from October 2003 to April 2010. Mean age at operation was 59 years (20~78 years), and 11 were male. Indications for TEVAR were large aortic diameter (>5.5 cm) upon presentation in 6 patients, increasing aortic diameter during the follow-up period in 4, traumatic aortic rupture in 3, persistent chest pain in 2, and ruptured aortic aneurysm in one. The mean diameter, length and the number of the stents were 33 mm (26~40 mm), 12 cm (9.5~16.0 cm), and 1.25 (1~2), respectively. Aortography employing Multi-detector computerized tomography (MDCT) technique was performed at one week, and patients were followed up in the out-patient department at one month, 6 months, and one year postoperatively.
Results: Primary technical success showing complete exclusion of the aneurysm was achieved in 15 patients. One patient showed a small endo-leak (type 1). Four patients developed perioperative stroke: Three recovered without sequelae, and one showed mild right-side weakness. There was no operative mortality. Diameter of the thoracic aorta covered by stent graft changed within 10% range in 12 patients, decreased by more than 10% in 3, and increased by more than 10% in one during mean follow-up duration of 18 months (1~73 months). There was no recurrence-related death during this period.
Conclusion: Intermediate-term outcome after TEVAR was encouraging. Indications for TEVAR could be extended for other thoracic aortic diseases.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249291 | PMC |
| http://dx.doi.org/10.5090/kjtcs.2011.44.2.148 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Integrated multi-omics profiling reveals neutrophil extracellular traps potentiate Aortic dissection progression.
Nat Commun
December 2024
Department of Vascular Surgery, Zhongshan Hospital, Fudan University, 200032, Shanghai, China.
Adverse aortic remodeling increases the risk of aorta-related adverse events (AAEs) after thoracic endovascular aortic repair (TEVAR) and affects the overall prognosis of aortic dissection (AD). It is imperative to delve into the exploration of prognostic indicators to streamline the identification of individuals at elevated risk for postoperative AAEs, and therapeutic targets to optimize the efficacy of TEVAR for patients with AD. Here, we perform proteomic and single-cell transcriptomic analyses of peripheral blood and aortic lesions, respectively, from patients with AD and healthy subjects.
View Article and Find Full Text PDFNeed for and update on clinical trials for uncomplicated type B aortic dissection.
JVS Vasc Insights
January 2024
Academic Department of Vascular Surgery, South Bank Section, School of Cardiovascular and Metabolic Medicine and Sciences, King's College London, British Heart Foundation Centre of Research Excellence, St Thomas' Hospital, London, UK.
The mainstay of management for uncomplicated type B aortic dissection is currently optimal medical therapy, targeting blood pressure and heart rate, along with serial imaging. There is a paucity of data that informs whether early intervention with thoracic endografting in this group of patients will promote aortic remodeling and better long-term outcomes. Investigations to date, including the Investigation of Stent Grafts in Aortic Dissection (INSTEAD), INSTEAD-XL, and Acute Dissection: Stent Graft or Best Medical Therapy (ADSORB) studies, have compared thoracic endovascular aortic repair (TEVAR) with optimal medical therapy in patients with uncomplicated type B aortic dissection but have not shown a benefit for TEVAR conclusively.
View Article and Find Full Text PDFTwenty-year results of open surgical suprarenal aortic fenestration for acute complicated type B aortic dissection.
Ann Vasc Surg
December 2024
Department of Interventional Radiology, Semmelweis University, Budapest, Hungary; Semmelweis Aortic Center, Heart and Vascular Center, Semmelweis University, Budapest, Hungary. Electronic address:
Objective: Open surgical suprarenal aortic fenestration (OSSAF) is a technique to treat complicated type B aortic dissection (cTBAD) by resecting the intimal membrane at the level of the visceral arteries. This invasive procedure is largely abandoned since the advent of thoracic endovascular aortic repair (TEVAR) as becoming the gold standard of treating cTBAD. Identifying patterns in the late history of patients who underwent OSSAF might help better understand the evolution of TBAD.
View Article and Find Full Text PDFSex-Based Differences of Thoracic Endovascular Aortic Repair for Stanford Type B Aortic Dissections.
Ann Vasc Surg
December 2024
Department of Surgery, Division of Vascular & Endovascular Surgery, UC San Diego, La Jolla, CA; Center for Learning and Excellence in Vascular and Endovascular Research, UC San Diego, La Jolla, CA. Electronic address:
Objective: There is a paucity of data on sex-based differences in outcomes after thoracic endovascular aortic repair (TEVAR) performed for Stanford type B aortic dissections (TBAD). Examining the predictive role of sex could shape future clinical guidelines for TEVAR. Thus, this study aims to evaluate the association between sex and postoperative outcomes after TEVAR performed for TBAD.
View Article and Find Full Text PDFInpatient Pediatric Clinical Consultations to Vascular Surgery within a Children's Hospital.
J Vasc Surg
December 2024
Division of Vascular Surgery, Loma Linda School of Medicine, 11175 Campus St, Loma Linda, CA 92350, USA. Electronic address:
Introduction: Acute pediatric vascular issues are infrequent and result in a diverse, unpredictable experience for vascular surgeons and trainees. We reviewed the indications for consult and resulting interventions provided by the Vascular Surgery (VS) service at a freestanding Children's Hospital (CH) adjacent to a university hospital.
Methods: Consults to VS at our CH were reviewed over a 4.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!